FPRX
Macquarie Group’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-100,000
| Closed | -$3.77M | – | 2596 |
|
2021
Q1 | $3.77M | Hold |
100,000
| – | – | 0.01% | 993 |
|
2020
Q4 | $1.7M | Hold |
100,000
| – | – | ﹤0.01% | 1152 |
|
2020
Q3 | $470K | Hold |
100,000
| – | – | ﹤0.01% | 1416 |
|
2020
Q2 | $610K | Hold |
100,000
| – | – | ﹤0.01% | 1308 |
|
2020
Q1 | $227K | Hold |
100,000
| – | – | ﹤0.01% | 1424 |
|
2019
Q4 | $459K | Hold |
100,000
| – | – | ﹤0.01% | 1417 |
|
2019
Q3 | $388K | Hold |
100,000
| – | – | ﹤0.01% | 1425 |
|
2019
Q2 | $603K | Hold |
100,000
| – | – | ﹤0.01% | 1315 |
|
2019
Q1 | $1.34M | Buy |
+100,000
| New | +$1.34M | ﹤0.01% | 1106 |
|
2016
Q2 | – | Sell |
-55,938
| Closed | -$2.27M | – | 1661 |
|
2016
Q1 | $2.27M | Buy |
55,938
+1,948
| +4% | +$79.2K | ﹤0.01% | 919 |
|
2015
Q4 | $2.24M | Buy |
53,990
+5,990
| +12% | +$249K | ﹤0.01% | 908 |
|
2015
Q3 | $739K | Buy |
+48,000
| New | +$739K | ﹤0.01% | 1180 |
|